FFAR2 and heart failure: Acetate can reduce the production of IL-6 and IL-8, while butyrate exerts anti-inflammatory effects by activating G protein-coupled receptor 43 and inducing the proliferation of regulatory T cells, thereby inhibiting the generation of Th17 cells and suppressing inflammatory responses and the progression of heart failure.